Medication refractory restless legs syndrome: Real-world experience
0
Authors
Peyman Petramfar
Peyman Petramfar•José Brás
Published
August 1, 2024
Abstract
Restless Legs Syndrome (RLS), impacting 5-13% of the population, poses challenges in long-term management. A knowledge gap exists in predicting resistance to first-line therapies.
